$NI

This NiSource Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday

Keybanc analyst Sophie Karp initiated coverage on NiSource Inc. (NYSE: NI) with an Overweight rating and a price target of $52. Additionally, BTIG analyst Marie Thibault began coverage on Minimed Group, Inc. (NASDAQ: MMED) with a Buy rating and a $25 price target, and HC Wainwright & Co. analyst Yi Chen initiated coverage on Envoy Medical, Inc. (NASDAQ: COCH) with a Buy rating and a $2.5 price target. These inaugurate Tuesday's top analyst initiations, reflecting bullish outlooks for the respective companies.

Original reporting
Benzinga · Avi Kapoor
Published Mar 31, 2026, 11:57 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Mar 31, 2026, 12:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
This NiSource Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday — source image
Decision brief

The 30-second read

$NIBullishMed
01

Why it matters

Positive analyst sentiment could lead to short-term price appreciation, especially in energy and utility sectors.

02

Market read

The news is highly relevant for investors interested in the utilities and healthcare sectors, with potential short-term trading opportunities.

03

What to watch

Regulatory changes, macroeconomic factors, or company fundamentals could influence actual performance beyond analyst expectations.

Timing: Immediate to short-term (next 1-3 months)

Background

Recent analyst coverage indicates institutional confidence in NiSource and related companies, reflecting sector optimism.

Company-level read

Ticker impact

$NIBullishHigh confidence
Context

High relevance due to recent analyst coverage and bullish sentiment.

Expected impact

Moderate upward price movement over the next 1-3 months, estimated at 5-10%.

Evidence & confidence

Multiple analysts initiating coverage with bullish ratings indicate strong institutional interest and positive sentiment, supported by the company's fundamentals and sector outlook.

$MMEDBullishMedium confidence
Context

Moderate relevance; coverage on Minimed Group, Inc. with a Buy rating and $25 target.

Expected impact

Potential 3-7% increase in short-term price, contingent on broader market conditions.

Evidence & confidence

While the buy rating is positive, the company's smaller market presence and sector influence limit immediate impact. Broader market trends will also influence the outcome.

$COCHBullishLow confidence
Context

Low relevance; coverage on Envoy Medical, Inc. with a Buy rating and $2.5 target.

Expected impact

Minimal immediate price change; potential long-term growth if fundamentals support.

Evidence & confidence

The company's niche focus and lower liquidity reduce the likelihood of significant short-term price movements based solely on analyst coverage.

Market effects

Positive sentiment in energy and utilities sectors, potentially boosting related stocks.

Primarily US-focused, with limited international influence.

Limited; sector-specific news with minimal global market impact.

Counterpoint

Analyst optimism may be overly optimistic; potential for sector headwinds or company-specific issues to temper gains.

Key entities

  • NiSource Inc.

    A utility company providing natural gas and electricity services.

  • Minimed Group, Inc.

    A medical device manufacturer specializing in minimally invasive procedures.

  • Envoy Medical, Inc.

    A medical device company focusing on hearing restoration technologies.

Related articles

$NIMedAI 8/10

How NiSource’s (NI) New Amazon and Alphabet Data Center Deals Have Changed Its Investment Story

NiSource Inc. (NI) reported Q2 2026 adjusted earnings that beat estimates but declined year-over-year. The company secured regulatory approvals for data center contracts with Amazon and Alphabet, expected to save customers $1.4B. NiSource reaffirmed its 2026 earnings guidance and plans significant capital investments, tying growth to data center demand and grid modernization. The stock projects $8.4B revenue and $1.3B earnings by 2029, a 21% upside from current prices.

$MMEDHighAI 8/10

Why MiniMed Stock Was Soaring This Week

MiniMed Group (MMED) shares rose 19% week-to-date after Q1 2027 results beat revenue expectations. Net sales grew 17% YoY to $843M, with international sales up 18%. The company launched MiniMed Flex insulin pump and raised full-year revenue guidance to 10.5% growth.

$MMEDMed

Biotech Stocks At 52-Week Highs - MMED +10%, PLSE, SOLV, RPRX, APGE

Several biotech stocks hit 52-week highs on September 1, 2026. MiniMed Group (MMED) rose 10% to $22.74 with 16.6% sales growth. Pulse Biosciences (PLSE) gained 3% to $54.39. Solventum (SOLV) reached $94.16 with 2.2% revenue growth. Royalty Pharma (RPRX) climbed to $62.58 with 14% royalty receipts growth. Apogee Therapeutics (APGE) hit $135.09 and will be acquired by AbbVie for $10.9B.